Document Detail


Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
MedLine Citation:
PMID:  16557585     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have recently demonstrated in a Phase I/II study that combination chemotherapy with docetaxel (TXT) and S-1 is active against metastatic gastric carcinomas. To elucidate the mechanisms underlying the synergistic effects of these drugs, both the growth inhibitory effects and the expression profiles of enzymes involved in fluorouracil (5-FU) metabolism were examined in vitro and in vivo. TXT alone and in combination with 5-FU inhibited the growth of each of the 5 gastric cancer cell lines that we examined (TMK-1, and MKN-1, -28, -45 and -74), in a time- and dose-dependent manner. Moreover, striking synergistic effects were observed in TMK-1 cells in vitro with IC50 values of between 4.73 and 0.61 nM 5-FU. Furthermore, in TMK-1 xenografts, 5-FU/TXT cotreatments exhibited synergistic antitumor effects. The combination of S-1 and TXT, however, exhibited greater growth-inhibitory effects than the 5-FU/TXT cotreatments. The mechanisms underlying these synergistic effects of S-1 and TXT were examined by expression and activity analyses of the 5-FU metabolic enzymes. The expression of thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) were decreased 50 and 73% of control levels, respectively, and that of orotate phosphorybosyl transferase (OPRT) was increased by 3.9-fold at the protein level. These findings suggested that biochemical modulation of the 2 drugs had occurred, which was further confirmed by the results of the activity assays. These data strongly indicate that a combination chemotherapy of TXT and S-1 is effective against gastric carcinomas and is therefore a good candidate as a standard chemotherapeutic strategy in treating these tumors.
Authors:
Yoshiyuki Wada; Kazuhiro Yoshida; Takahisa Suzuki; Hirozumi Mizuiri; Kazuo Konishi; Kei Ukon; Kazuaki Tanabe; Yu Sakata; Masakazu Fukushima
Related Documents :
21936805 - Measurement of exercise-induced oxidative stress in lymphocytes.
16955805 - Temporal relationship between gastrointestinal protein loss, gastric ulceration or eros...
11093625 - Reduction of renal function in exercising horses.
11037265 - Haemodynamic response to exercise in standardbred trotters with red cell hypervolaemia.
14652505 - The effects of klapskate hinge position on push-off performance: a simulation study.
17209695 - A transdisciplinary model integrating genetic, physiological, and psychological correla...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  119     ISSN:  0020-7136     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-06-08     Completed Date:  2006-08-09     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  783-91     Citation Subset:  IM    
Copyright Information:
Copyright 2006 Wiley-Liss, Inc.
Affiliation:
Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line, Tumor
Cell Proliferation / drug effects
Dihydrouracil Dehydrogenase (NADP) / metabolism
Drug Combinations
Drug Synergism
Female
Fluorouracil / metabolism*
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Mice
Mice, Nude
Multienzyme Complexes / genetics,  metabolism
Orotate Phosphoribosyltransferase / genetics,  metabolism
Orotidine-5'-Phosphate Decarboxylase / genetics,  metabolism
Oxonic Acid / pharmacology*
Stomach Neoplasms / enzymology*,  pathology
Taxoids / pharmacology*
Tegafur / pharmacology*
Thymidylate Synthase / metabolism
Xenograft Model Antitumor Assays
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Multienzyme Complexes; 0/Taxoids; 150863-82-4/S 1 (combination); 15H5577CQD/docetaxel; 17902-23-7/Tegafur; 51-21-8/Fluorouracil; 74870-74-9/uridine 5'-monophosphate synthase; 937-13-3/Oxonic Acid; EC 1.3.1.2/Dihydrouracil Dehydrogenase (NADP); EC 2.1.1.45/Thymidylate Synthase; EC 2.4.2.10/Orotate Phosphoribosyltransferase; EC 4.1.1.23/Orotidine-5'-Phosphate Decarboxylase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or...
Next Document:  Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (h...